RhumbLine Advisers’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20M Sell
283,168
-7,721
-3% -$417K 0.02% 754
2026
Q1
$15.2M Buy
290,889
+9,809
+3% +$589K 0.01% 855
2025
Q4
$16.5M Sell
281,080
-20,087
-7% -$1.22M 0.01% 811
2025
Q3
$16.8M Buy
301,167
+6,546
+2% +$351K 0.01% 829
2025
Q2
$15.2M Sell
294,621
-5,853
-2% -$294K 0.01% 858
2025
Q1
$17.6M Buy
300,474
+39,345
+15% +$2.67M 0.02% 750
2024
Q4
$18.8M Sell
261,129
-646
-0.2% -$47.4K 0.02% 736
2024
Q3
$20.9M Sell
261,775
-10,347
-4% -$778K 0.02% 684
2024
Q2
$19.5M Sell
272,122
-26,997
-9% -$1.99M 0.02% 687
2024
Q1
$21.1M Buy
299,119
+1,384
+0.5% +$99K 0.02% 681
2023
Q4
$23M Sell
297,735
-445
-0.1% -$29.3K 0.02% 598
2023
Q3
$20.3M Sell
298,180
-49,257
-14% -$3.89M 0.02% 622
2023
Q2
$28.4M Buy
347,437
+3,543
+1% +$285K 0.03% 476
2023
Q1
$25.5M Buy
343,894
+23,480
+7% +$1.81M 0.03% 494
2022
Q4
$26.6M Buy
320,414
+8,350
+3% +$663K 0.04% 454
2022
Q3
$22.2M Buy
312,064
+8,928
+3% +$771K 0.03% 490
2022
Q2
$26.3M Buy
303,136
+6,496
+2% +$609K 0.04% 425
2022
Q1
$32.1M Buy
296,640
+3,016
+1% +$311K 0.04% 381
2021
Q4
$38M Buy
293,624
+5,896
+2% +$723K 0.05% 349
2021
Q3
$34.9M Sell
287,728
-174,676
-38% -$21.3M 0.05% 347
2021
Q2
$52.1M Sell
462,404
-10,768
-2% -$1.13M 0.07% 250
2021
Q1
$45.2M Sell
473,172
-10,088
-2% -$920K 0.06% 272
2020
Q4
$38.4M Sell
483,260
-14,896
-3% -$1.08M 0.05% 309
2020
Q3
$30.9M Sell
498,156
-45,740
-8% -$2.98M 0.05% 337
2020
Q2
$35.9M Buy
543,896
+37,180
+7% +$2.23M 0.06% 288
2020
Q1
$24M Buy
506,716
+24,292
+5% +$1.22M 0.05% 335
2019
Q4
$26.5M Sell
482,424
-3,404
-0.7% -$179K 0.04% 377
2019
Q3
$23.8M Sell
485,828
-9,276
-2% -$465K 0.04% 389
2019
Q2
$25.8M Sell
495,104
-4,568
-0.9% -$230K 0.05% 365
2019
Q1
$24.8M Sell
499,672
-13,652
-3% -$614K 0.05% 357
2018
Q4
$18.6M Buy
513,324
+108,056
+27% +$4.51M 0.04% 442
2018
Q3
$20.7M Buy
405,268
+7,432
+2% +$329K 0.04% 436
2018
Q2
$14.7M Sell
397,836
-1,400
-0.4% -$53.5K 0.03% 531
2018
Q1
$15.1M Buy
399,236
+42,876
+12% +$1.51M 0.03% 525
2017
Q4
$11.5M Sell
356,360
-6,108
-2% -$194K 0.02% 623
2017
Q3
$11M Sell
362,468
-45,264
-11% -$1.34M 0.02% 619
2017
Q2
$12M Sell
407,732
-4,240
-1% -$116K 0.03% 570
2017
Q1
$10.5M Buy
411,972
+3,624
+0.9% +$93.5K 0.02% 626
2016
Q4
$10.5M Buy
408,348
+9,460
+2% +$249K 0.03% 598
2016
Q3
$10.9M Sell
398,888
-5,456
-1% -$150K 0.03% 540
2016
Q2
$11.4M Buy
404,344
+21,028
+5% +$541K 0.03% 491
2016
Q1
$9.06M Buy
383,316
+14,000
+4% +$308K 0.03% 577
2015
Q4
$8.31M Buy
369,316
+6,980
+2% +$159K 0.03% 587
2015
Q3
$8.38M Sell
362,336
-21,260
-6% -$533K 0.03% 573
2015
Q2
$9.44M Buy
383,596
+9,124
+2% +$228K 0.03% 547
2015
Q1
$9.39M Buy
374,472
+29,328
+8% +$697K 0.03% 555
2014
Q4
$7.97M Buy
345,144
+3,740
+1% +$85.6K 0.02% 576
2014
Q3
$7.99M Sell
341,404
-36,880
-10% -$864K 0.02% 553
2014
Q2
$8.75M Sell
378,284
-27,764
-7% -$614K 0.03% 536
2014
Q1
$8.67M Buy
406,048
+21,980
+6% +$495K 0.03% 556
2013
Q4
$9.09M Sell
384,068
-21,552
-5% -$467K 0.03% 517
2013
Q3
$8.12M Sell
405,620
-51,820
-11% -$983K 0.03% 581
2013
Q2
$7.9M Buy
+457,440
New +$7.59M 0.03% 562

Other funds holding TECH

RhumbLine Advisers's TECH Position: Q2 2026 in Review

RhumbLine Advisers reduced its Bio-Techne (TECH) stake by 2.7% in Q2 2026, selling an estimated $417K and leaving 283,168 shares worth $20M. The position accounts for 0.02% of the portfolio, ranked #754.

RhumbLine Advisers first reported a position in TECH in Q2 2013 and has held it in 53 quarters since. The position peaked at $52.1M in Q2 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • RhumbLine Advisers held 283,168 shares of Bio-Techne worth $20M as of Q2 2026.
  • RhumbLine Advisers sold 7,721 Bio-Techne shares in Q2 2026, an estimated $417K.
  • Bio-Techne made up 0.02% of RhumbLine Advisers's portfolio in Q2 2026, its #754 holding.
  • RhumbLine Advisers first reported a position in Bio-Techne in Q2 2013 and has held it in 53 quarters since.
  • RhumbLine Advisers's Bio-Techne position peaked at $52.1M in Q2 2021.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.